Thumbnail

COVID-19 complicated by high Venous Thromboembolism (VTE) and bleed risk in critically ill patients.

  • Study reports abnormally high VTE and high bleed risk in critically ill COVID-19 patients and calls for more effective prevention strategies.
  • Clinicians at NHS hospitals are supporting the care of COVID-19 patients with the use of geko™ devices to reduce the risk of blood clots in the most at risk patients.
 Learn more Contact us

Clinical Studies

Through our central vision in driving innovation through collaborative partnerships to solve challenging medical problems, we have placed research at the heart of our business.

Our sponsored and investigator-led studies translate clinical needs into high-impact evidence-based therapies.

To review our body of research, please click one or more filters to refine your search.

Refresh

Increased Blood Circulation – Patient Data

The use of a novel neuromuscular electrical stimulation device in peripheral vascular disease

Author(s): Katherine J. Williams, Alun H. Davies

Paper

Increased Blood Circulation – Patient Data

Neuromuscular electrical stimulation for the prevention of venous thromboembolism

Author(s): Ravikumar R, Williams KJ, Babber A, Moore HM, Lane TRA, Shalhoub J, Davies AH.

Paper

Oedema Reduction

Use of a Muscle Pump Activator Leads to Improved Lower Limb Edema, Lower Limb Blood Flow, and Urine Output Compared With Standard TED Stockings and Compression Devices Following Kidney Transplant: A Randomized Controlled Trial

Author(s): Shahid Aquil, Bijad Alharbi, Roshan Navaratnam, Hemant Sharma, Patrick P.Luke, Alp Sener

Paper

Oedema Reduction

A Single-Centre Feasibility Randomised Controlled Trial Comparing the Incidence of Asymptomatic and Symptomatic Deep Vein Thrombosis Between a Neuromuscular Electrostimulation Device and Thromboembolism Deterrent

Author(s): Wainwright T W

Paper

VTE prevention

The use of the geko™ device and the activation of the foot and calf pumps for prevention of venous thromboembolism in patients with acute stroke

Author(s): Williams J, Roffe C, Natarajan I, Moss C, Lambert C, Richards L

AbstractPosterFind out more

Oedema Reduction

Does neuromuscular electrical stimulation improve recovery following acute ankle sprain? A pilot randomised controlled trial

Author(s): Wainwright T W, Burgess L C, Middleton R G

Paper

Wound Therapy

A novel method of assessment of microcirculatory changes with the use of geko™ device in patients with venous leg ulcers

Author(s): Das S, Dhoonmoon L, Bain D, Chhabra S

Poster

Wound Therapy

Daily use of a muscle pump activator device reduces hospitalization and improves graft function post-transplantation: A randomized controlled trial

Author(s): Yan Xie W, Levine M, Aquil S, Pacoli K, Al-Ogaili R, Luke P, Sener A

Abstract

Increased Blood Circulation – Patient Data

The Impact of Peripheral Nerve Stimulation on Coronary Blood Flow and Endothelial Function

Author(s): Anthony C. Camuglia, Mistre Alemayehu, Andrew McLellan, Sabrina Wall, Nour Abu-Romeh, Shahar Lavi

Paper

Wound Therapy

Using a muscle pump activator device to stimulate healing for non-healing lower leg wounds in long term care residents

Author(s): Harris C, Ramage D, Boloorchi, Vaughan L, Kuilder G, Rakas S.

AbstractPaper

Increased Blood Circulation – Healthy Subject Data

The effect of a novel electrical stimulation method for improving lower limb blood flow in healthy volunteers

Author(s): Jawad H

Paper

The geko™ device Annotated Bibliography

Annotated Bibliography

VTE prevention

Clinical observation of neuromuscular electrical stimulation in prevention of deep venous thrombosis after total hip replacement

Author(s): Jingwei L, Zhe Z, Xuesong L, Hui J, Ning L, Wenbo W

Paper

VTE prevention

Prevention of Postoperative Leg Vein Thrombosis by Electrical Muscle Stimulation. An Evaluation with ¹²⁵ I-Labelled Fibrinogen

Author(s): Browse N L, Negus D

Paper

VTE prevention

Prophylaxis of postoperative leg vein thrombosis by low dose subcutaneous heparin or peroperative calf muscle stimulation: a controlled clinical trial.

Author(s): Rosenberg I L , Evans M, Pollock A V

Paper
Next